The Long-Term Effects of Short-Period Adalimumab Biosimilar Usage in Ankylosing Spondylitis

Background Cost and drug toxicity frequently deter the long-term use of anti-tumor necrosis factor (TNF) agents in ankylosing spondylitis (AS). Therefore, this study was conducted to observe long-term relief after the short-term administration of an anti-TNF agent. Methodology A one-year, prospectiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Chopra, Arvind, Khadke, Nagnath, Saluja, Manjit, Kianifard, Toktam, Venugopalan, Anuradha, Gharia, Mihir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10030650/
https://www.ncbi.nlm.nih.gov/pubmed/36960229
http://dx.doi.org/10.7759/cureus.36444

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10030650/
https://www.ncbi.nlm.nih.gov/pubmed/36960229
http://dx.doi.org/10.7759/cureus.36444

Ejemplares similares